![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Eckert Siegfried Horstkotte Dieter
Publisher: Adis International
ISSN: 1175-3277
Source: American Journal of Cardiovascular Drugs, Vol.9, Iss.1, 2009-01, pp. : 17-28
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Trimetazidine for stable angina pectoris
By Cross H.R.
Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 5, 2001-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Fluorouracil: Angina pectoris: case report
Reactions Weekly, Vol. 1, Iss. 1395, 2012-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Insight to the Pathophysiology of Stable Angina Pectoris
Current Pharmaceutical Design, Vol. 19, Iss. 9, 2013-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Ivabradine noninferior to atenolol in angina pectoris
Inpharma, Vol. 1, Iss. 1524, 2006-01 ,pp. :